![ruler](https://www.lachmanconsultants.com/wp-content/uploads/2020/07/iStock-643768366-scaled.jpg)
OGD Quarterly Activities Report – Look What’s Going On!
In the Generic Drug User Fee Amendments Reauthorization Act (GDUFA II), OGD committed to provide a quarterly report with certain metrics regarding their workload and mean and median approval times for full approval actions and tentative approval actions. As you can see from the numbers below, the number of ANDAs awaiting action at OGD is […]